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ABSTRACT
Background
Red meat and processed meat have been associated with carcinogenesis at several anatomic
sites, but no prospective study has examined meat intake in relation to a range of malignancies.
We investigated whether red or processed meat intake increases cancer risk at a variety of sites.
Methods and Findings
The National Institutes of Health (NIH)-AARP (formerly the American Association for Retired
Persons) Diet and Health Study is a cohort of approximately 500,000 people aged 50–71 y at
baseline (1995–1996). Meat intake was estimated from a food frequency questionnaire
administered at baseline. Cox proportional hazards regression was used to estimate hazard
ratios and 95% confidence intervals within quintiles of red and processed meat intake. During
up to 8.2 y of follow-up, 53,396 incident cancers were ascertained. Statistically significant
elevated risks (ranging from 20% to 60%) were evident for esophageal, colorectal, liver, and
lung cancer, comparing individuals in the highest with those in the lowest quintile of red meat
intake. Furthermore, individuals in the highest quintile of processed meat intake had a 20%
elevated risk for colorectal and a 16% elevated risk for lung cancer.
Conclusions
Both red and processed meat intakes were positively associated with cancers of the
colorectum and lung; furthermore, red meat intake was associated with an elevated risk for
cancers of the esophagus and liver.
The Editors’ Summary of this article follows the references.
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Much of the global variation in cancer incidence has been
attributed to environmental inﬂuences, including dietary
preferences. Not only does meat intake vary substantially
around the world, but diets high in red or processed meats
have been associated with carcinogenesis at a variety of
anatomic sites. The evidence to support a positive association
between meat intake and carcinogenesis is based on an
assortment of research ranging from laboratory studies [1–3]
to observational epidemiology [4–8].
Thus far, the majority of epidemiologic meat research has
focused on the more prevalent cancers, particularly color-
ectal cancer. The most recent meta-analysis of prospective
studies of meat and colorectal cancer reported signiﬁcantly
elevated summary relative risks (RRs) for both red meat (RR¼
1.28; 95% conﬁdence interval (CI)¼1.15–1.42) and processed
meat (RR ¼ 1.20; 95% CI ¼ 1.11–1.31) in the highest versus
lowest category of intake [9]. To date, ﬁndings for other major
cancers—such as prostate, breast, lung, and pancreatic
cancer—are less consistent. Prospective data for rarer
cancers are sparse, and most epidemiologic studies of less–
commonly occurring cancers are restricted to case-control
studies, for which investigations of dietary associations are
difﬁcult, because of the potential for recall bias [10].
We prospectively investigated red and processed meat
intake in relation to cancer incidence in a cohort of
approximately half a million men and women enrolled in
the National Institutes of Health (NIH)-AARP (formerly
known as the American Association for Retired Persons) Diet
and Health Study. This study’s large size facilitated the
investigation of comparatively rare cancers that have not yet
been prospectively investigated.
Materials and Methods
Study Population
The NIH-AARP Diet and Health Study is a large prospec-
tive cohort of men and women, aged 50–71 y, from six states
in the United States (California, Florida, Louisiana, New
Jersey, North Carolina, and Pennsylvania) and two metropol-
itan areas (Atlanta, Georgia; and Detroit, Michigan). Recruit-
ment began in 1995 when a self-administered questionnaire
eliciting information on demographic and lifestyle character-
istics, including dietary habits, was mailed to 3.5 million
members of AARP; further details of the design of the study
have been described in detail elsewhere [11,12]. The NIH-
AARP Diet and Health Study was approved by the Special
Studies Institutional Review Board of the US National Cancer
Institute, and written informed consent was obtained from all
participants by virtue of completing the baseline question-
naire.
Dietary Assessment
A 124-item food frequency questionnaire (FFQ), based on
the Diet History Questionnaire (http://riskfactor.cancer.gov/
DHQ/forms/ﬁles/shared/dhq1.2002.sample.pdf), developed at
the National Cancer Institute, was completed at baseline. The
FFQ assessed the usual frequency of consumption and
portion size information (based on three categories of
,25th, 25th–75th, and .75th percentile of intake from
national dietary data) of foods and drinks over the previous
12 mo. Portion sizes and daily nutrient intakes were
calculated from the 1994–1996 US Department of Agricul-
ture’s Continuing Survey of Food Intake by Individuals [13].
The FFQ compared favorably to other FFQs [14], and was also
calibrated within this study population against two 24-h recall
diaries [12]. Red meat intake was calculated from the
frequency of consumption and portion size information of
all types of beef, pork, and lamb; this included bacon, beef,
cold cuts, ham, hamburger, hot dogs, liver, pork, sausage, and
steak. The processed meat variable included bacon, red meat
sausage, poultry sausage, luncheon meats (red and white
meat), cold cuts (red and white meat), ham, regular hot dogs,
and low-fat hot dogs made from poultry. The meat variables
also included meats added to complex food mixtures, such as
pizza, chili, lasagna, and stew.
Cohort Follow-Up and Case Ascertainment
Cohort members are followed annually for change of
address using the US Postal Service, and vital status is
ascertained by annual linkage to the US Social Security
Administration Death Master File. Follow-up for these
analyses was calculated from baseline (1995–1996) until
censoring at the end of 2003, or when the participant moved
out of one of the eight study areas, had a cancer diagnosis, or
died, whichever came ﬁrst. Cancer cases were identiﬁed by
linkage to state cancer registries and the National Death
Index Plus. The eight state cancer registry databases are
estimated to be 95% complete within 2 y of cancer incidence
and are certiﬁed by the North American Association of
Central Cancer Registries for meeting the highest standard of
data quality [11]. Cancer diagnoses contributed to the
incidence of the tumor site of the ﬁrst diagnosis only and
not subsequent diagnoses for additional sites. The cancer
endpoints were deﬁned by anatomic site and histologic code
of the International Classiﬁcation of Diseases for Oncology
(ICD-0–3) [15]. Advanced prostate cancer may have a distinct
etiology; therefore, we used the Tumor-Node-Metastasis
classiﬁcation system [16], and deﬁned those with clinical or
pathologic stage T3, T4, or N1 or M1, as well as individuals
who died of prostate cancer, to have advanced disease. Results
are presented for cancer sites with at least 60 cases within
each sex.
Statistical Analysis
A total of 567,169 persons returned the baseline question-
naire and were available for analysis. We excluded individuals
with duplicate records (n ¼ 179), those who died before
returning the baseline questionnaire (n¼261), those who had
zero person years of follow-up (n¼32), those who moved out
of the eight study areas before returning the questionnaire (n
¼ 269), those who requested to be withdrawn from the study
(n ¼ 1), those whose questionnaire was ﬁlled in by someone
else on their behalf (n ¼ 15,765), those who had prevalent
cancer (as noted by cancer registry or self-report) at baseline
(n ¼ 51,212) or end-stage renal disease (n ¼ 997), and those
with extreme daily total energy intake (n ¼ 4,417), deﬁned as
more than two inter-quartile ranges above the 75th or below
the 25th percentile on the logarithmic scale. After all
exclusions, our analytic cohort consisted of 494,036 persons
(294,724 men and 199,312 women).
Hazard ratios (HRs) and 95% CIs were estimated using Cox
proportional hazards regression with time since entry (person
years) as the underlying time metric. Analyses using age as the
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controlled for age as a continuous variable in the Cox model;
inclusion of a quadratic term for age did not improve the ﬁt
of the model, nor did it modify the HRs appreciably.
Multivariate HRs are reported within quintiles, using the
lowest quintile as the referent category, adjusted for the
covariates listed in the tables. Missing data were minimal for
this study; where appropriate—i.e., for smoking history and
body mass index (BMI)—we created ‘‘missing’’ categories, but
for others, such as family history of cancer, we set individuals
missing this data to zero: no family history. Saturated fat
intake and menopausal hormone therapy were investigated as
potential confounders of the meat–cancer association, but
neither proved to change the HR by greater than 10% and
were not, therefore, included in the ﬁnal models. Extremely
ﬁne control for smoking history and dosage was investigated,
by constructing a 31-level variable using smoking status
(never, former, current), time since quitting for former
smokers, and smoking dose.
We examined models that were adjusted for energy by two
different methods: the multivariate nutrient density method
and the residual energy adjustment method [10]. Since both
methods of energy adjustment gave similar results in our
study, and because the interpretation of the multivariate
nutrient density method applies to actual intakes as a percent
of energy, which tends to be the units expressed for public
health recommendations, we report the results from the
multivariate nutrient density adjusted models.
Risks are reported for both sexes combined, unless there
was a statistically signiﬁcant interaction between meat intake
and sex. Interactions were evaluated by including cross
product terms in multivariate models. Furthermore, we
conducted a lag analysis, excluding the ﬁrst 2 y of follow-
up, as well as various subanalyses to verify the stability of our
risk estimates within subgroups of race, BMI, education,
smoking status, physical activity level, and alcohol intake. The
proportional hazards assumption was veriﬁed using a time
interaction model. Tests for linear trend were calculated
using the median value of each quintile. All reported p-values
are two-sided. To test for heterogeneity, we used a chi-square
test. To test for heterogeneity among the 21 cancer sites with
20 degrees of freedom, we ﬁrst calculated the weighted
average of the 21 beta coefﬁcients from the Cox model, with
weights being proportional to the inverse of the variances.
Then we calculated the following chi-square statistic:
T ¼
P21
i¼1ð^ bi     bÞ
2=r2
i , where ^ bi and r2
i are the coefﬁcient
and its variance for each cancer, and   b is the weighted
average of the beta coefﬁcients. Likewise, to test for
heterogeneity between subsites, such as colon versus rectum,
we used the same chi-squared test given above, but using one
degree of freedom. We also calculated population-attribut-
able risks as an estimate of the percentage of cases that could
be prevented if individuals adopted intake levels within the
ﬁrst quintile, given the assumption of a causal association
between red or processed meat intake and cancer. All
statistical analyses were carried out using Statistical Analytic
Systems (SAS) software (SAS Institute).
Results
During a mean follow-up of 6.8 y, 53,396 cancer diagnoses
(36,907 male cases and 16,489 female cases) were ascertained.
The mean energy–adjusted red meat intake in this cohort was
34.6 g/1,000 kcal (38.0 g/1,000 kcal in men and 29.5 g/1,000
kcal in women). The medians of extreme quintiles ranged
from 9.8 to 62.7 g/1,000 kcal for red meat and 1.6 to 22.6 g/
1,000 kcal for processed meat.
In general, those in the highest quintile of red meat intake
tended to be slightly younger, less educated, less physically
active, and less likely to consume fruits, vegetables, and
alcohol than those in the lowest quintile. In contrast, those in
the highest quintile of red meat intake were more likely to
have a higher total energy intake, a higher BMI, and more
likely to be a current smoker. Women in the highest quintile
of red meat intake were also more likely to be married than
those in the lowest quintile (Table 1).
Red Meat
Individuals in the highest quintile of red meat intake,
compared with those in lowest, had a statistically signiﬁcant
elevated risk of several malignancies (Table 2), including
esophageal (HR ¼ 1.51; 95% CI ¼ 1.09–2.08; p for trend ¼
0.13), colorectal (HR¼1.24; 95% CI¼1.12–1.36; p for trend ,
0.001, liver (HR¼1.61; 95% CI¼1.12–2.31; p for trend¼0.04),
lung (HR¼1.20; 95% CI¼1.10–1.31; p for trend , 0.001), and
borderline statistical signiﬁcance for laryngeal cancer (HR ¼
1.43; 95% CI ¼ 0.99–2.07; p for trend ¼ 0.09). The positive
association for red meat intake and colorectal cancer was due
more to cancer of the rectum (n¼1,418; HR¼1.45; 95% CI¼
1.20–1.75; p for trend , 0.001) than the colon (n¼3,689; HR¼
1.17; 95% CI ¼ 1.05–1.31; p for trend , 0.001), and this
difference in risk was marginally statistically signiﬁcant (p for
heterogeneity¼0.06). Additional ﬁne control for smoking did
not alter the associations for cancers of the esophagus,
colorectum, liver, lung, or larynx. In addition, the tests for
interaction between smoking and both red meat (p inter-
action ¼ 0.69) and processed meat (p interaction ¼ 0.48)
intake for lung cancer risk were not statistically signiﬁcant.
The population-attributable risks, representing the percent-
age of cases that could be prevented if individuals adopted
red meat intake levels within the ﬁrst quintile, were 33%, 9%,
35%, and 10% for esophageal, colorectal, liver, and lung
cancer, respectively.
Red meat intake was not associated with gastric or bladder
cancer, leukemia, lymphoma, or melanoma. The associations
between red meat and cancer are summarized in Figure 1,
arranged by order of the magnitude of the risk; the ﬁgure also
shows the null ﬁndings for sex-speciﬁc cancers, such as breast,
ovarian, cervical, and prostate cancer. Unexpectedly, red
meat intake was inversely associated with endometrial cancer
(HR ¼ 0.75; 95% CI ¼ 0.62–0.91; p for trend ¼ 0.02).
In further sex-speciﬁc analyses, red meat intake was
positively associated with pancreatic cancer among men only
(HR ¼ 1.43; 95% CI ¼ 1.11–1.83; p for trend ¼ 0.001; p
interaction by sex¼0.03); this risk was not attenuated by ﬁne
control for smoking. We observed no differences in risk by
sex for other cancer sites.
Processed Meat
Individuals in the highest quintile, compared with those in
the lowest quintile, of processed meat intake were at elevated
risk for colorectal (HR¼1.20; 95% CI¼1.09–1.32; p for trend
, 0.001) and lung cancer (HR ¼ 1.16; 95% CI ¼ 1.06–1.26; p
for trend¼0.001) (Table 3). In concordance with the red meat
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ectal cancer was slightly higher for rectal (HR¼1.24; 95% CI
¼1.03–1.49; p for trend¼0.03) than colon cancer (HR¼1.18;
95% CI ¼ 1.06–1.32; p for trend ¼ 0.001), although this
difference in risk was not statistically signiﬁcant (p for
heterogeneity ¼ 0.67). Additional ﬁne control for smoking
did not alter the risk estimates for cancers of the colorectum
or lung. Furthermore, borderline statistically signiﬁcant
increased risks for bladder cancer (HR ¼ 1.16; 95% CI ¼
0.98–1.38; p for trend ¼ 0.26) and myeloma (HR ¼ 1.30; 95%
CI¼ 0.98–1.71; p for trend ¼ 0.01) were observed for those in
the highest quintile of processed meat intake. The popula-
tion-attributable risks, representing the proportion of cases
potentially preventable if individuals adopted processed meat
intake levels within the ﬁrst quintile, were 10% for colorectal
cancer and 9% for lung cancer.
Surprisingly, both leukemia and melanoma were inversely
associated with processed meat intake; the inverse association
for leukemia was mainly for lymphocytic leukemia (n ¼ 534;
HR ¼ 0.70; 95% CI ¼ 0.52–0.93; p for trend ¼ 0.05) and not
myeloid and monocytic leukemia (n¼457; HR¼0.88; 95% CI
¼ 0.64–1.20; p for trend ¼ 0.73). The associations between
processed meat intake and cancer risk are summarized in
Figure 2, in order of risk magnitude.
Sex-speciﬁc analyses revealed a positive association for
men in the highest quintile of processed meat consumption
for pancreatic cancer (HR ¼ 1.31; 95% CI ¼ 1.01–1.68; p for
trend ¼ 0.05; p interaction ¼ 0.01); this association was not
attenuated by ﬁne control for smoking. Furthermore, women
in the highest quintile of processed meat had a borderline
statistically signiﬁcant elevated risk for cervical cancer (HR¼
1.72; 95% CI ¼ 0.96–3.09; p for trend ¼ 0.01).
Further analyses did not reveal differences in risk
associated with either red or processed meat intake for
Table 1. Means and Proportions for Baseline Characteristics of the NIH-AARP Diet and Health Study Cohort (n¼494,036) by Red Meat
Quintile
Sex Parameter Characteristics Quintile Red Meat Intake
Q1 Q2 Q3 Q4 Q5
Men (n ¼ 294,724) Red meat (g/1,000 kcal) 12.0 24.7 35.1 46.8 67.0
Age (y) 62.6 62.5 62.2 62.0 61.4
Race Non-Hispanic white (%) 89.0 92.1 93.2 94.3 93.9
Non-Hispanic black (%) 4.0 3.0 2.6 2.0 1.9
Hispanic, Asian, Pacific Islander,
American Indian, Alaskan native,
or unknown (%)
6.9 4.9 4.2 3.7 4.2
Positive family history of cancer (%) 46.0 47.0 47.5 47.3 46.9
Currently married (%) 81.3 85.1 86.4 86.6 85.4
Body mass index (kg/m
2) 26.1 26.9 27.3 27.7 28.4
Smoking history
a Never smoker (%) 34.3 30.6 29.1 27.8 25.8
Former smoker (%) 57.1 57.6 56.8 56.1 54.8
Current smoker or having
quit , 1ya g o( % )
6.7 9.9 12.3 14.2 17.5
Education, college graduate or post graduate (%) 51.8 46.7 43.9 41.6 38.5
Vigorous physical activity,   5 times per week (%) 29.4 22.7 20.0 18.1 16.0
Dietary intakes Energy (kcal/d) 1911 1965 2009 2059 2127
Fruit (servings/1,000 kcal) 2.2 1.7 1.5 1.3 1.1
Vegetables (servings/1,000 kcal) 2.3 2.0 2.0 2.0 1.9
Alcohol (g/d) 20.6 19.3 16.7 14.8 12.2
Women (n ¼ 199,312) Red meat (g/1,000 kcal) 7.8 17.6 26.3 36.5 54.7
Age (y) 62.1 62.1 62.0 61.7 61.3
Race Non-Hispanic white (%) 85.2 88.7 90.2 91.4 91.3
Non-Hispanic black (%) 8.1 6.2 5.4 4.3 4.0
Hispanic, Asian, Pacific Islander,
American Indian, Alaskan native,
or unknown (%)
6.7 5.0 4.4 4.3 4.7
Positive family history of cancer (%) 50.0 51.6 51.7 51.9 50.5
Currently married (%) 36.6 41.0 45.0 48.2 50.5
Body mass index (kg/m
2) 25.4 26.4 26.9 27.4 28.2
Smoking history
a Never smoker (%) 46.6 45.6 44.8 43.6 41.5
Former smoker (%) 41.7 39.0 37.4 35.8 34.0
Current smoker or
having quit , 1ya g o( % )
9.7 13.5 16.0 18.7 22.7
Education, college graduate or post graduate (%) 38.2 31.8 29.0 26.6 23.3
Vigorous physical activity,   5 times per week (%) 23.9 17.6 15.0 12.9 11.3
Dietary intakes Energy (kcal/d) 1528 1530 1557 1600 1639
Fruit (servings/1,000 kcal) 2.6 2.2 1.9 1.6 1.4
Vegetables (servings/1,000 kcal) 2.9 2.5 2.4 2.3 2.3
Alcohol (g/d) 5.5 6.3 6.3 5.9 5.2
The associations across quintiles of red meat were all statistically significant (p , 0.01), except for family history of cancer in women.
a5,573 (1.9%) men and 3,794 (1.9%) women have missing smoking history data.
doi:10.1371/journal.pmed.0040325.t001
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versus non-cardia gastric cancer, and pre- versus post-
menopausal breast cancer (unpublished data). However, we
observed a suggestion of an elevated risk for advanced
prostate cancer (n¼1,782), for both red meat (HR¼1.15; 95%
CI¼0.98–1.36; p for trend¼ 0.21) and processed meat intake
(HR ¼ 1.22; 95% CI ¼ 1.05–1.43; p for trend ¼ 0.08), when
comparing those in the highest with those in the lowest
quintile of intake.
We conducted sensitivity analyses excluding processed
meats from the red meat variable to determine whether the
risks associated with red and processed meat are independent
of each other. The removal of processed meats from the red
meat variable reduced the median intake of red meat from
31.4 g/1,000 kcal to 23.6 g/1,000 kcal. The positive associations
for red meat and cancer of the liver, esophagus, colorectum,
and lung all remain when processed meats were removed
from the red meat variable. Furthermore, the inverse
Table 2. Multivariate HRs and 95% CIs (Both Sexes Combined) for Red Meat Intake and Cancer in the NIH-AARP Diet and Health Study
Cancer Site Statistic Red Meat Intake Quintiles p for Trend
Q1 Q2 Q3 Q4 Q5
Median
a red meat
intake (g/1,000 kcal)
9.8 21.4 31.4 42.9 62.7 —
Oral cavity and
pharyngeal
Cases (men/women) 113/57 106/43 139/66 144/55 196/38 —
HR (95% CI) Ref 0.80 (0.64–1.00) 1.04 (0.84–1.29) 0.95 (0.77–1.19) 1.03 (0.82–1.28) 0.41
Laryngeal Cases (men/women) 37/10 45/18 79/16 81/18 103/9 —
HR (95% CI) Ref 1.12 (0.76–1.64) 1.51 (1.05–2.17) 1.43 (0.99–2.06) 1.43 (0.99–2.07) 0.09
Esophageal Cases (men/women) 48/14 98/17 90/17 103/18 130/13 —
HR (95% CI) Ref 1.56 (1.14–2.14) 1.33 (0.97–1.84) 1.39 (1.01–1.92) 1.51 (1.09–2.08) 0.13
Gastric Cases (men/women) 72/42 92/31 90/27 130/22 130/22 —
HR (95% CI) Ref 1.02 (0.78–1.32) 0.92 (0.71–1.21) 1.14 (0.88–1.48) 1.05 (0.81–1.38) 0.48
Colorectal Cases (men/women) 472/418 570/346 674/299 820/318 935/255 —
HR (95% CI) Ref 0.98 (0.89–1.08) 1.03 (0.94–1.14) 1.20 (1.09–1.31) 1.24 (1.12–1.36) ,0.001
Liver Cases (men/women) 38/17 56/18 65/19 68/20 89/13 —
HR (95% CI) Ref 1.33 (0.93–1.90) 1.49 (1.04–2.12) 1.51 (1.05–2.16) 1.61 (1.12–2.31) 0.04
Pancreatic Cases (men/women) 101/100 118/83 126/88 149/77 226/35 —
HR (95% CI) for men Ref 1.02 (0.80–1.31) 1.02 (0.80–1.32) 1.12 (0.87–1.44) 1.43 (1.11–1.83) 0.001
HR (95% CI) for women Ref 0.92 (0.66–1.28) 1.13 (0.81–1.56) 1.25 (0.90–1.74) 0.92 (0.64–1.32) 0.92
Lung Cases (men/women) 474/506 660/566 890/467 997/512 1280/417 —
HR (95% CI) Ref 1.07 (0.98–1.17) 1.11 (1.02–1.21) 1.16 (1.07–1.27) 1.20 (1.10–1.31) ,0.001
Bladder Cases (men/women) 188/57 251/60 282/63 310/45 372/38 —
HR (95% CI) Ref 1.08 (0.91–1.28) 1.10 (0.92–1.30) 1.05 (0.88–1.24) 1.12 (0.94–1.33) 0.33
Kidney Cases (men/women) 134/87 178/85 192/78 225/70 267/47 —
HR (95% CI) Ref 1.07 (0.89–1.28) 1.03 (0.86–1.24) 1.06 (0.88–1.27) 1.04 (0.86–1.25) 0.96
Thyroid Cases (men/women) 33/55 33/56 35/29 24/38 48/21 —
HR (95% CI) Ref 1.05 (0.78–1.42) 0.79 (0.56–1.10) 0.79 (0.56–1.12) 0.92 (0.64–1.30) 0.41
Non-Hodgkin
lymphoma
Cases (men/women) 202/159 227/160 279/132 280/129 277/76 —
HR (95% CI) Ref 1.04 (0.90–1.21) 1.09 (0.94–1.27) 1.08 (0.93–1.26) 0.93 (0.79–1.09) 0.30
Leukemia Cases (men/women) 129/80 130/61 144/55 166/44 188/40 —
HR (95% CI) Ref 0.84 (0.69–1.03) 0.84 (0.69–1.03) 0.86 (0.70–1.06) 0.91 (0.74–1.12) 0.68
Melanoma Cases (men/women) 234/157 239/110 280/100 341/79 315/77 —
HR (95% CI) Ref 0.84 (0.73–0.98) 0.90 (0.78–1.04) 0.99 (0.85–1.14) 0.95 (0.81–1.11) 0.54
Brain Cases (men/women) 71/36 67/46 94/33 79/25 80/20 —
HR (95% CI) Ref 1.02 (0.78–1.34) 1.12 (0.85–1.47) 0.89 (0.67–1.19) 0.85 (0.63–1.15) 0.20
Myeloma Cases (men/women) 61/51 60/40 75/41 81/25 92/19 —
HR (95% CI) Ref 0.89 (0.67–1.17) 1.04 (0.79–1.36) 0.96 (0.72–1.28) 1.03 (0.77–1.39) 0.59
Prostate Cases 2,777 3,117 3,588 3,803 3,950 —
HR (95% CI) Ref 1.01 (0.97–1.06) 1.04 (0.99–1.09) 1.02 (0.97–1.07) 1.01 (0.96–1.07) 0.58
Female breast Cases 1,485 1,351 1,292 1,006 738 —
HR (95% CI) Ref 1.05 (0.96–1.14) 1.07 (0.99–1.17) 1.09 (1.00–1.19) 1.02 (0.93–1.12) 0.75
Endometrial Cases 333 274 236 204 138 —
HR (95% CI) Ref 0.80 (0.67–0.96) 0.85 (0.70–1.01) 0.78 (0.64–0.94) 0.75 (0.62–0.91) 0.02
Ovarian Cases 149 131 92 110 70 —
HR (95% CI) Ref 1.20 (0.92–1.56) 0.97 (0.73–1.28) 1.09 (0.82–1.45) 1.19 (0.89–1.59) 0.33
Cervical C a s e s 2 9 2 12 71 62 4—
HR (95% CI) Ref 0.64 (0.33–1.25) 1.09 (0.61–1.96) 1.02 (0.55–1.87) 1.05 (0.57–1.94) 0.44
Multivariate model includes: age (continuous), sex, education (,8 y or unknown, 8–11 y, 12 y [high school], some college, college graduate), marital status, family history of cancer, race
(non-Hispanic white, non-Hispanic black, Hispanic/Asian/Pacific Islander/American Indian/Alaskan native, or unknown), BMI (18.5 to ,25, 25 to ,30, 30 to ,35,  35 kg/m
2), smoking
(never, quit   10y ago, quit 5–9 y ago, quit 1–4 y ago, quit , 1y or currently smoking and smoked  20 cigs/day, quit , 1y ago or currently smoking and smoked .20 cigs/d), frequency
of vigorous physical activity (never/rarely, 1–3 times/mo, 1–2 times/wk, 3–4 times/wk, 5 or more times/wk), total energy intake (continuous), alcohol intake (none, 0 to ,5, 5 to ,15, 15 to
,30,  30 g/d), and fruit and vegetable consumption (quintiles).
aNutrient density energy adjusted.
Ref, reference group.
doi:10.1371/journal.pmed.0040325.t002
PLoS Medicine | www.plosmedicine.org December 2007 | Volume 4 | Issue 12 | e325 1977
Meat Intake and Cancer Incidenceassociation for red meat and endometrial cancer remained
after removing processed meats.
In a lag analysis excluding the ﬁrst two years of follow-up,
both the positive and the inverse associations reported in this
study remained. A stepwise addition of the covariates to a
simple age- and sex-adjusted model showed that the effects of
red and processed meat intake on cancer risk were
attenuated the most by the addition of the smoking variable
to the models. Subanalyses showed that there was no clear
gradient in risk for colorectal or lung cancer across categories
of education, BMI, physical activity, or alcohol intake. With
regard to race, the increased risk observed for red and
processed meat and cancer of the colorectum and lung was
not evident for blacks, although this ethnicity only repre-
sented 3.8 and 4.0 percent of the cases for each cancer site,
respectively, and therefore the conﬁdence intervals were
wide. The risks for lung cancer associated with both red and
processed meat intake were apparent across all categories of
smoking.
Discussion
In this large, prospective investigation of red and processed
meat intake in relation to cancer risk, we found elevated risks
for colorectal and lung cancer with both meat types. Red, but
not processed, meat intake was also associated with increased
risk for cancer of the esophagus and liver. We observed
borderline statistically signiﬁcant elevated risks for advanced
prostate cancer with both red and processed meat intake, for
laryngeal cancer with red meat, and for bladder cancer and
myeloma and with processed meat intake.
The cancer site most consistently associated with meat
intake has been the colorectum. A recent meta-analysis of 15
prospective studies published through March, 2006, included
approximately 7,500 cases, and reported elevated risks in the
highest category of consumption of 28% for red meat and
20% for processed meat [9]. Our study included over 5,000
colorectal cancer cases, and it lends strong support to
implicate red and processed meat as risk factors for this
malignancy. Consistent with previous studies [9], we observed
a stronger positive association for rectal than colon cancer.
The positive associations for both red and processed meat
that we report for lung cancer were of similar magnitude to
the ﬁndings for colorectal cancer. To date, our study includes
the largest prospective analysis of meat intake and lung
cancer risk. Previous case-control studies have reported
elevated risks for lung cancer for those in the highest
categories of red meat [17–19], fried red meat [8,19], well-
done red meat [17], and processed meat intake [20]. Despite
conducting analyses to show that very ﬁne control of smoking
history, using a 31-level variable, did not attenuate the lung
cancer associations, there remains a potential issue of
residual confounding by smoking, because it is such a strong
risk factor for this disease.
We found a positive association between red meat intake
speciﬁcally and cancers of the esophagus and liver, and a
borderline signiﬁcant positive association for laryngeal
cancer. The ﬁrst prospective study of meat intake and
esophageal cancer was published recently; that study had
only 65 cases and found a positive association for processed
meat, but not red meat, with esophageal adenocarcinoma
[21]. Our study suggests a threshold effect for red meat intake
on esophageal cancer risk, beginning at a low level of intake,
with no further increase in risk with higher intakes, as
reﬂected in the p-trend (p ¼ 0.13), although it is possible that
the referent group had a smaller-than-expected cancer
incidence by chance. Data on meat intake and cancers of
the liver and larynx are limited, and our study is the ﬁrst
Figure 1. HRs and 95% CIs for the 5th Versus 1st Quintile of Red Meat Intake and Cancer Risk for Both Sexes Combined (Except for Sex-Specific Cancers)
doi:10.1371/journal.pmed.0040325.g001
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case-control studies reported elevated risks for laryngeal
cancer for those in the highest intake categories of red meat
intake [22,23] and fried beef/veal [24].
In our study, those in the highest quintile of processed
meat intake had borderline statistically signiﬁcant elevated
risks for myeloma, a malignancy that has not been well-
studied for dietary associations, and bladder cancer. A study
of two prospective cohorts combined [25], and one case-
control study [26], both found elevated risks of bladder
cancer for those in the highest categories of processed meat
consumption, but another cohort study found no association
[27].
Unexpectedly, we found an inverse association between red
Table 3. Multivariate HRs and 95% CIs (Both Sexes Combined) for Processed Meat Intake and Cancer in the NIH-AARP Diet and Health
Study
Cancer Site Statistic Processed Meat Intake Quintiles p for Trend
Q1 Q2 Q3 Q4 Q5
Median
a processed meat
intake (g/1,000 kcal)
1.6 4.4 7.6 12.3 22.6 —
Oral cavity and
pharyngeal
Cases (men/women) 102/58 133/54 123/54 148/43 192/50 —
HR (95% CI) Ref 1.07 (0.86–1.32) 0.96 (0.76–1.20) 0.97 (0.78–1.22) 1.17 (0.94–1.45) 0.14
Laryngeal Cases (men/women) 32/16 57/16 75/15 79/18 102/6 —
HR (95% CI) Ref 1.23 (0.85–1.79) 1.35 (0.94–1.94) 1.32 (0.92–1.90) 1.33 (0.93–1.91) 0.31
Esophageal Cases (men/women) 69/17 76/22 90/20 116/10 118/10 —
HR (95% CI) Ref 0.95 (0.71–1.28) 0.96 (0.72–1.29) 1.00 (0.75–1.34) 0.94 (0.70–1.25) 0.69
Gastric Cases (men/women) 75/45 90/30 87/24 119/20 143/25 —
HR (95% CI) Ref 0.92 (0.71–1.19) 0.78 (0.60–1.03) 0.90 (0.69–1.17) 1.00 (0.78–1.30) 0.44
Colorectal Cases (men/women) 443/408 572/371 697/308 827/298 932/251 —
HR (95% CI) Ref 1.05 (0.96–1.16) 1.09 (0.99–1.20) 1.18 (1.07–1.30) 1.20 (1.09–1.32) ,0.001
Liver Cases (men/women) 47/17 57/20 61/19 69/21 82/10 —
HR (95% CI) Ref 1.13 (0.81–1.59) 1.11 (0.79–1.56) 1.16 (0.82–1.64) 1.09 (0.77–1.53) 0.82
Pancreatic Cases (men/women) 75/105 132/101 124/76 192/61 197/40 —
HR (95% CI) for men Ref 1.24 (0.96–1.59) 1.06 (0.82–1.38) 1.39 (1.09–1.79) 1.31 (1.01–1.68) 0.05
HR (95% CI) for women Ref 1.03 (0.74–1.42) 1.16 (0.84–1.60) 1.00 (0.71–1.40) 0.86 (0.60–1.22) 0.18
Lung Cases (men/women) 456/548 693/571 843/494 1075/450 1234/405 —
HR (95% CI) Ref 1.08 (1.00–1.18) 1.07 (0.99–1.17) 1.16 (1.06–1.26) 1.16 (1.06–1.26) 0.001
Bladder Cases (men/women) 174/50 236/67 283/55 330/58 380/33 —
HR (95% CI) Ref 1.13 (0.95–1.35) 1.14 (0.96–1.36) 1.19 (1.00–1.42) 1.16 (0.98–1.38) 0.26
Kidney Cases (men/women) 109/93 176/76 197/80 244/65 270/53 —
HR (95% CI) Ref 1.13 (0.93–1.36) 1.15 (0.95–1.39) 1.20 (0.99–1.45) 1.18 (0.98–1.43) 0.22
Thyroid Cases (men/women) 30/60 29/48 34/26 35/37 45/28 —
HR (95% CI) Ref 0.88 (0.65–1.21) 0.71 (0.51–1.00) 0.89 (0.64–1.25) 0.93 (0.67–1.31) 0.86
Non-Hodgkin
lymphoma
Cases (men/women) 165/180 247/148 253/131 298/108 302/89 —
HR (95% CI) Ref 1.10 (0.95–1.28) 1.05 (0.90–1.22) 1.08 (0.93–1.26) 1.03 (0.88–1.20) 0.85
Leukemia Cases (men/women) 126/79 128/61 155/60 163/49 185/31 —
HR (95% CI) Ref 0.83 (0.67–1.01) 0.88 (0.72–1.08) 0.82 (0.67–1.01) 0.80 (0.65–0.98) 0.13
Melanoma Cases (men/women) 243/158 237/114 295/98 312/100 322/53 —
HR (95% CI) Ref 0.81 (0.70–0.94) 0.88 (0.76–1.02) 0.90 (0.78–1.04) 0.82 (0.71–0.96) 0.13
Brain Cases (men/women) 69/36 81/44 82/31 82/25 77/24 —
HR (95% CI) Ref 1.14 (0.88–1.49) 1.01 (0.76–1.33) 0.94 (0.70–1.25) 0.88 (0.65–1.18) 0.15
Myeloma Cases (men/women) 50/54 57/41 65/31 86/20 111/30 —
HR (95% CI) Ref 0.94 (0.71–1.25) 0.91 (0.68–1.22) 0.98 (0.74–1.31) 1.30 (0.98–1.71) 0.01
Prostate Cases 2,549 3,120 3,512 3,858 4,196 —
HR (95% CI) Ref 1.01 (0.97–1.06) 1.01 (0.97–1.07) 1.01 (0.96–1.06) 1.02 (0.97–1.07) 0.60
Female breast Cases 1,606 1,354 1,192 963 757 —
HR (95% CI) Ref 1.04 (0.96–1.13) 0.94 (0.87–1.03) 1.09 (1.00–1.18) 1.03 (0.94–1.12) 0.38
Endometrial Cases 316 287 210 198 174 —
HR (95% CI) Ref 0.93 (0.77–1.12) 0.99 (0.82–1.20) 0.91 (0.75–1.11) 1.02 (0.84–1.23) 0.56
Ovarian Cases 145 136 109 96 66 —
HR (95% CI) Ref 1.14 (0.87–1.50) 1.21 (0.91–1.59) 1.13 (0.85–1.51) 1.23 (0.92–1.63) 0.30
Cervical Cases 28 25 17 23 24 —
HR (95% CI) Ref 0.97 (0.52–1.81) 0.77 (0.39–1.51) 1.05 (0.55–1.98) 1.72 (0.96–3.09) 0.01
Multivariate model includes: age (continuous), sex, education (,8 y or unknown, 8–11 y, 12 y [high school], some college, college graduate), marital status, family history of cancer, race
(non-Hispanic white, non-Hispanic black, Hispanic/Asian/Pacific Islander/American Indian/Alaskan native, or unknown), BMI (18.5 to ,25, 25 to ,30, 30 to ,35,  35 kg/m
2), smoking
(never, quit  10 y ago, quit 5–9 y ago, quit 1–4 y ago, quit ,1y or currently smoking and smoked  20 cigs/d, quit ,1 y ago or currently smoking and smoked .20 cigs/d), frequency of
vigorous physical activity (never/rarely, 1–3 times/mo, 1–2 times/wk, 3–4 times/wk, 5 or more times/wk), total energy intake (continuous), alcohol intake (none, 0 to ,5, 5 to ,15, 15 to
,30,  30 g/d), and fruit and vegetable consumption (quintiles).
a Nutrient density energy adjusted.
Ref, reference group.
doi:10.1371/journal.pmed.0040325.t003
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Meat Intake and Cancer Incidencemeat intake and endometrial cancer; this association was not
attenuated by adjustment for known risk factors, such as body
mass index or menopausal hormone therapy, or by ﬁne
control for smoking, which has been inversely associated with
this malignancy [28]. Previous studies have reported null
[29,30] or positive relations [31] between red meat and
endometrial cancer. We also observed inverse associations
between processed meat intake and leukemia and melanoma.
In contrast to our ﬁndings, childhood leukemia has been
positively associated with intake of processed meats in a case-
control study [32].
Both red and processed meat intake were positively
associated with pancreatic cancer in men, but not women.
Red meat has been associated with pancreatic cancer in some
[33,34], but not all [35–39] previous cohort studies, as has
processed meat in one cohort [34] and several case-control
studies [40–44]; although a sex-speciﬁc association has not
been reported before. Although the association between
pancreatic cancer and red or processed meat intake in men
was unchanged by ﬁne control for smoking, residual
confounding by smoking is still possible.
Our study did not reveal an association between red or
processed meat intake and gastric, prostate, or breast cancer,
or non-Hodgkin lymphoma. In contrast to the positive
relation between both red and processed meat intakes and
noncardia gastric cancer in a large cohort in Europe [21], we
found no differences in risk according to gastric anatomic
subsite. The evidence for a positive association between meat
intake and gastric cancer has been more consistent for
processed meat than red meat, with elevated risks for
processed meat in several case-control [45–52] and cohort
studies [53–57], whereas red meat has been positively
associated in some [45,46], but not all studies [47,58,59].
Previous studies of meat intake and prostate cancer are
conﬂicting. Some studies have reported null ﬁndings [5,60–
66], and others suggest positive associations [67–74]. Despite
ﬁnding no association between red or processed meat intake
and overall prostate cancer risk, we observed a suggestion of
an elevated risk for advanced prostate cancer with both meat
types. If the relation of meat intake to prostate cancer is
conﬁned to advanced disease, this could explain some of the
inconsistencies in the literature as most previous studies have
not speciﬁcally addressed advanced prostate cancer.
With regard to breast cancer, a pooled analysis of eight
cohort studies found no association with red meat intake [75];
however, the two most recent prospective studies found
positive associations for both red and processed meat [76],
speciﬁcally for estrogen and progesterone receptor–positive
breast cancers in premenopausal women [77]. Although
breast cancer risk related to meat intake did not appear to
differ by menopausal status in our study, we had very few
premenopausal cases (n ¼ 94) and lacked information on
hormone receptor status for a large number of cases.
In agreement with our ﬁndings, the majority of studies of
red meat and non-Hodgkin lymphoma have been null [78–
85], although elevated risks were reported in some studies
[86–88]; similarly, of nine studies investigating processed
meat and non-Hodgkin lymphoma [79–82,84,86–89], only two
found a positive association [81,89]. In contrast to our null
ﬁndings, some case-control studies have reported positive
associations for red or processed meat intake and cancer of
the oral cavity, pharynx [90,91], kidney [92], ovaries [83],
thyroid [83], and brain [93], although data for these cancer
sites are limited.
Both red meat, regardless of processing procedure, and
processed meat can be linked to carcinogenesis by different
Figure 2. HRs and 95% CIs for the 5th Versus 1st Quintile of Processed Meat Intake and Cancer Risk for Both Sexes Combined (Except for Sex-Specific
Cancers)
doi:10.1371/journal.pmed.0040325.g002
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Meat Intake and Cancer Incidencemechanisms; for example, they are both sources of saturated
fat and iron, which have independently been associated with
carcinogenesis. Associations between saturated fat and
cancer are likely to be related to energy balance in general,
whereas iron is thought to contribute to carcinogenesis
speciﬁcally by generating free radicals and inducing oxidative
stress [94]. Most recently, dietary fat was positively associated
with breast cancer [95], and iron intake was positively
associated with liver [96] and colorectal cancers [97].
Meat is also a source of several known mutagens, including
N-nitroso compounds (NOCs), heterocyclic amines (HCAs),
and polycyclic aromatic hydrocarbons (PAHs). Exposure to
NOCs occurs from endogenous formation, which is directly
related to red meat intake [98], and from exogenous exposure
from nitrite-preserved meats, for example [1]. Red meat is a
large source of readily available heme iron, which has been
associated with increased endogenous NOC formation [99].
Human exposure to NOCs and subsequent cancer risk has
not been studied extensively; although a Finnish cohort
reported an increased risk of colorectal cancer with
exogenous exposure to N-nitrosodimethylamine (from
smoked and salted meats) [6]. In addition, NOC intake and
excretion were signiﬁcantly greater in an area within China
considered as high-risk for esophageal cancer [100]. HCAs
and PAHs, which are formed during high-temperature
cooking of meat [101], dose-dependently generate DNA
adducts [3] and tumors in rodents [2,102] in a wide variety
of tissues and organs, with similarities between experimental
animals and humans [103]. Epidemiologic studies with the
capacity to estimate HCA and PAH intake from meat cooking
information have found elevated risks of colorectal neoplasia
[104–106], squamous cell esophageal cancer [107], as well as
cancers of the lung [8], pancreas [4], and prostate [5].
With regard to the stronger relation of red and processed
meat to rectal cancer than to colon cancer, there is variation
in several characteristics along the large intestine; for
example, the average crypt length [108], apoptotic index
[109], and propensity to form 0
6-methylguanine adducts[110]
(pro-carcinogenic and a marker of NOC exposure) is greater
toward the rectum than in the proximal colon. Furthermore,
there is variation throughout the colorectum in bacterial
enzymes [111], in the fermentation of short chain fatty acids
[112], in the expression of metabolic enzymes [113], and in the
concentration of fecal matter, in which potential carcinogens
are concentrated toward the rectum.
Despite abundant biologic pathways linking meat intake to
carcinogenesis at numerous anatomic sites, this is the ﬁrst
comprehensive and prospective analysis of meat intake in
relation to a full range of malignancies. A particular strength
of this study includes the large size of the cohort, which
enabled us to investigate low-incidence cancers that have not
previously been prospectively explored. Our ﬁndings are
strictly generalizable to US whites over 50 y old, but may
readily extend to other populations, because it is unlikely that
the mechanisms relating meat to carcinogenesis differ
quantitatively between our study population and those to
whom our results do not strictly apply. An additional strength
was that our study encompassed a wide range of reported
meat intake, providing adequate statistical power to detect
associations. Furthermore, recall bias and reverse causation
were minimized by the assessment of diet prior to cancer
diagnoses.
Potential limitations of this study include some degree of
measurement error associated with the assessment of dietary
and lifestyle variables. The FFQ used in this study was
compared with two 24-h recall diaries in a subgroup of
individuals from this cohort. The energy-adjusted correlation
coefﬁcients for protein and saturated fat, the two most
relevant macronutrients for meat, were 0.43 and 0.50 for men
and women, respectively, for protein, and 0.76 and 0.69 for
men and women, respectively, for saturated fat [114]. These
correlations compared very favorably to other commonly
used FFQs that have correlations ranging from 0.29 to 0.61 in
men and from 0.16 to 0.67 in women for protein intake and
from 0.64 to 0.76 in men and from 0.59 to 0.76 in women for
saturated fat intake [114]. Furthermore, the correlations for
red meat assessed from the FFQ compared with two 24-h
recall dairies were 0.62 for men and 0.70 for women [12].
Although some measurement error remains, the error
associated with FFQs tends to result in attenuated risks
[115], and we attempted to minimize this error by energy
adjustment of the models [116]. With regard to nondietary
covariates, reviews and meta-analyses have concluded that
self-reported smoking behavior is accurate in most studies as
assessed by plasma cotinine levels [117], and the correlations
for physical activity assessment in questionnaires similar to
that used in our study produce reasonable correlations [118].
Furthermore, self-reported height and weight is a reliable
method of estimating BMI.
Some of the observed associations between meat intake and
cancer risk in our study may be explained by exposure to
HCAs and PAHs from meats cooked well-done by high-
temperature cooking techniques; however, we lacked data on
detailed cooking preferences from baseline. In addition,
because we analyzed cancer incidence at multiple sites, some
of our ﬁndings may have occurred by chance.
In conclusion, a diet high in red or processed meat was
associated with an elevated risk of both colorectal and lung
cancer; in addition, red meat was associated with an elevated
risk of esophageal and liver cancer. A decrease in the
consumption of red and processed meat could reduce the
incidence of cancer at multiple sites.
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Editors’ Summary
Background. Every year, there are more than 10 million new cases of
cancer around the world. These cases are not spread evenly across the
globe. The annual incidence of cancer (the number of new cases divided
by the population size) and the type of cancer most commonly
diagnosed varies widely among countries. Much of the global variation
in cancer incidence and type is thought to be due to environmental
influences. These include exposure to agents in the air or water that
cause cancer, and lifestyle factors such as smoking and diet. Researchers
identify environmental factors that affect cancer risk by measuring the
exposure of a large number of individuals to a specific environmental
factor and then monitoring these people for several years to see who
develops cancer. The hope is that by identifying the environmental
factors that cause or prevent cancer, the global burden of cancer can be
reduced.
Why Was This Study Done? Diet is thought to influence the incidence
of several cancers but it is very difficult to unravel which aspects of diet
are important. Being overweight, for example, is strongly associated with
an increased risk of developing several types of cancer, but the evidence
that the intake of red meat (beef, pork, and lamb) and of processed meat
(for example, bacon, ham, and sausages) is linked to cancer risk is much
weaker. Although several studies have linked a high intake of red meat
and processed meat to an increased risk of colorectal cancer (the colon is
the large bowel; the rectum is the final few inches of the large bowel
before the anus), whether this aspect of diet affects the risk of other
types of cancer is unclear. In this prospective study, the researchers have
examined the association between meat intake and the incidence of a
wide range of cancers.
What Did the Researchers Do and Find? In 1995–1996, nearly half a
million US men and women aged 50–71 y joined the NIH-AARP Diet and
Health Study. The participants in this study—none of whom had had
cancer previously—completed a questionnaire about their dietary habits
over the previous year and provided other personal information such as
their age, weight, and smoking history. The researchers used these data
and information from state cancer registries to look for associations
between the intake of red and processed meat and the incidence of
various cancers. They found that people whose red meat intake was in
the top fifth of the range of intakes recorded in the study (the highest
quintile of consumption) had an increased risk of developing colorectal,
liver, lung, and esophageal cancer when compared with people in the
lowest quintile of consumption. People in the highest quintile of
processed meat intake had an increased risk of developing colorectal
and lung cancer. The incidences of other cancers were largely unaffected
by meat intake.
What Do These Findings Mean? These findings provide strong
evidence that people who eat a lot of red and processed meats have
greater risk of developing colorectal and lung cancer than do people
who eat small quantities. They also indicate that a high red meat intake is
associated with an increased risk of esophageal and liver cancer, and that
one in ten colorectal and one in ten lung cancers could be avoided if
people reduced their red and processed meat intake to the lowest
quintile. However, although the researchers allowed for factors such as
smoking history that might have affected cancer incidences, some of the
effects they ascribe to meat intake might be caused by other lifestyle
factors. Furthermore, because the study’s definitions of red meat and
processed meat overlapped—bacon and ham, for example, were
included in both categories—exactly which type of meat is related to
cancer remains unclear. Finally, most of the study participants were non-
Hispanic white, so these findings may not apply to people with different
genetic backgrounds. Nevertheless, they add to the evidence that
suggests that decreased consumption of red and processed meats could
reduce the incidence of several types of cancer.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0040325.
  The American Cancer Society provides answers to common questions
about diet and cancer
  Information is available from the charity Cancer Research UK about
diet, healthy eating, and cancer
  The American Institute for Cancer Research also provides information
on diet and cancer.
  The NIH-AARP Diet and Health Study presents information on the
impact of diet and lifestyle factors on risk of cancer
  The US National Cancer Institute provides information about the kind
of food questionnaire used in this study
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